Sort by 'likes'
Racing Toward An Ebola Vaccine, But What About A Cure?
In the absence of a proven cure for EBOLA, researchers across the country are in a frenzy to get the one vaccine which can prevent the spread of this deadly disease and also provide people offering medical care to the…
What you need to know about the ICER report and its implication on insurance coverage and treatment options for myeloma patients.
Cancer drugs cost more than $100,000 per year and continue to increase. Medicare has proposed major changes to Medicare Part B in an attempt to slow the explosion in healthcare expenditures. In addition, a recent “report” by a group called…
Inherited Gene Mutations in Myeloma and Role of Precision Medicine
Multiple Myeloma is the second most common cancer of the blood and is largely incurable. A recent study has found that a specific gene mutation can increase the risk of developing myeloma six to nine fold. The lead author of…
Screen. Prevent. Treat. For Colorectal Cancer Management
March is National Colorectal Cancer Awareness Month. According to the American Cancer Society, there will be more than 100,000 new cases of colon cancer and more than 44,000 rectal cancer cases diagnosed in 2019. Colorectal cancer may cause over 50,000…
Targeting Stem Cells in Multiple Myeloma for Improved Outcomes
Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns…